Briacell Therapeutics Corp • BCTX

Capital at risk.

About Briacell Therapeutics Corp
Ticker
info
BCTX
Trading on
info
NASDAQ
ISIN
info
CA10778Y3023
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Dr. William V. Williams M.D.
Headquarters
info
Bellevue Centre, West Vancouver, BC, Canada, V7T 2X1
Employees
info
0
Website
info
https://briacell.com
BriaCell Therapeutics Corp., a clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted cell-based immunotherapy that is being evaluated in a pivotal Phase 3 combination study for metastatic breast cancer. The company is also developing Bria-OTS, a platform of personalized off-the-shelf cell-based immunotherapies, which is being evaluated in a Phase 1/2 clinical studies targeting breast cancer with extension to prostate cancer and other cancers. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp. is based in West Vancouver, Canada.
Metrics
BasicAdvanced
Market cap
info
$15.9M
P/E ratio
info
-
EPS
info
-$4.75
Dividend Yield
info
0.00%
Beta
info
1.86
Forward P/E ratio
info
0
EBIDTA
info
$-27.2M
Ex dividend date
info
-
Price & volume
Market cap
info
$15.9M
Average daily volume
info
0.1M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
0
Price to book
info
4.4
Earnings
EPS
info
-$4.75
EPS estimate (current quarter)
info
$0.00
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-27.2M
Revenues (TTM)
info
$0M
Revenues per share (TTM)
info
$0.00
Technicals
Beta
info
1.86
52-week High
info
$45.45
52-week Low
info
$3.00
50-day moving average
info
$3.00
200-day moving average
info
$1.38
Short ratio
info
0.21
Short %
info
5.16%
Management effectiveness
ROE (TTM)
info
536.81%
ROA (TTM)
info
158.14%
Profit margin
info
0.00%
Gross profit margin
info
$0M
Operating margin
info
0.00%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
0.00%
Share stats
Outstanding Shares
info
3.7M
Float
info
3.2M
Insiders %
info
12.96%
Institutions %
info
14.05%
Analyst Insights & forecasts
info

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

info
$23.50
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.11
-$0.55
120.00%
Q2 • 24Beat
-$0.07
-$0.46
84.78%
Q3 • 24Beat
-$0.22
-$0.30
26.67%
Q4 • 24Beat
-$2.33
-$1.94
20.10%
Q1 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-5.8M
∞%
Q4 • 24
$0M
$-6.3M
∞%
Q1 • 25
NaN%
8.43%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$10.4M
$6.7M
64.35%
Q4 • 24
$9.4M
$6.1M
65.54%
Q1 • 25
10.09%
8.43%
1.85%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-7M
$-0.1M
$12M
$-7M
Q4 • 24
$-5.9M
$-0.1M
$5.2M
$-5.9M
Q1 • 25
14.88%
-
56.38%
14.88%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Briacell Therapeutics Corp share?
Collapse

Briacell Therapeutics Corp shares are currently traded for undefined per share.

How many shares does Briacell Therapeutics Corp have?
Collapse

Briacell Therapeutics Corp currently has 3.7M shares.

Does Briacell Therapeutics Corp pay dividends?
Collapse

No, Briacell Therapeutics Corp doesn't pay dividends.

What is Briacell Therapeutics Corp 52 week high?
Collapse

Briacell Therapeutics Corp 52 week high is $45.45.

What is Briacell Therapeutics Corp 52 week low?
Collapse

Briacell Therapeutics Corp 52 week low is $3.00.

What is the 200-day moving average of Briacell Therapeutics Corp?
Collapse

Briacell Therapeutics Corp 200-day moving average is $1.38.

Who is Briacell Therapeutics Corp CEO?
Collapse

The CEO of Briacell Therapeutics Corp is Dr. William V. Williams M.D..

How many employees Briacell Therapeutics Corp has?
Collapse

Briacell Therapeutics Corp has 0 employees.

What is the market cap of Briacell Therapeutics Corp?
Collapse

The market cap of Briacell Therapeutics Corp is $15.9M.

What is the P/E of Briacell Therapeutics Corp?
Collapse

The current P/E of Briacell Therapeutics Corp is null.

What is the EPS of Briacell Therapeutics Corp?
Collapse

The EPS of Briacell Therapeutics Corp is -$4.75.

What is the PEG Ratio of Briacell Therapeutics Corp?
Collapse

The PEG Ratio of Briacell Therapeutics Corp is null.

What do analysts say about Briacell Therapeutics Corp?
Collapse

According to the analysts Briacell Therapeutics Corp is considered a buy.